Health Care Stocks

Drug makers, biotechnology, medical devices, laboratory instruments, health insurers and hospitals. 185 companies worth $6.7T together, at a median P/E of 25.7.

In Vitro & In Vivo Diagnostic Substances

Largest first.

Company	Market value	P/E	Yield	From 52-week high	Short interest
IDEXX Laboratories IncIDXXIn Vitro & In Vivo Diagnostic Substances	$40.9B$518.00	35.9×	—	-32.4%	2.5%
Lantheus Holdings IncLNTHIn Vitro & In Vivo Diagnostic Substances	$6.5B$100.15	23.7×	—	-9.7%	5.8%
Neogen CorpNEOGIn Vitro & In Vivo Diagnostic Substances	$2.6B$11.85	—	—	-15.2%	5.4%
Intellia Therapeutics IncNTLAIn Vitro & In Vivo Diagnostic Substances	$1.8B$13.07	—	—	-53.3%	32.2%
QuidelOrtho CorpQDELIn Vitro & In Vivo Diagnostic Substances	$916.6M$13.42	—	—	-62.1%	21.9%

Industries are the SEC's own codes for each company. Market value is the latest close times the shares on the latest filing; P/E is left out where earnings are not positive.

Related datasets

Whale MovesAnyone crossing five per cent, and whether they want a say.Institutional HoldingsWhich funds own these companies, and what they changed.Stock ScreensPiotroski, Graham, dividend records and most shorted.Fund Manager CommentaryWhat well-known funds' managers say drove their year.